Abbott clinical biochemical glucose test panel - Taiwan Registration 24f7e0b33f08effdb8a70e2252d41af3
Access comprehensive regulatory information for Abbott clinical biochemical glucose test panel in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 24f7e0b33f08effdb8a70e2252d41af3 and manufactured by ABBOTT GMBH;; SEKISUI DIAGNOSTICS P.E.I. INC.. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ABBOTT LABORATORIES, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
24f7e0b33f08effdb8a70e2252d41af3
DHA00601828305
Product Details
Quantify glucose in human serum, plasma, urine, or cerebrospinal fluid (CSF).
A Clinical chemistry and clinical toxicology
A.1345 Glucose Test System
Contract manufacturing;; input
Dates and Status
Jun 07, 2007
Jun 07, 2027